ZACHARY GAMBLE
Allopathic & Osteopathic Physicians|Psychiatry & Neurology|Psychiatry GREENEVILLE, TN NPI 1669901435
Browse related groups: Allopathic & Osteopathic Physicians|Psychiatry & Neurology|Psychiatry TN Supernus Pharmaceuticals, Inc. All categories
General Payments — all program years on this page
$529.98
- Category: General Payments
- Program years: PY2022–2024
- Record count: 22
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $198.24 across 8 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $198.24 | 8 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| Supernus Pharmaceuticals, Inc. | $83.65 | 2 |
| Axsome Therapeutics, Inc. | $40.65 | 2 |
| Janssen Pharmaceuticals, Inc | $23.70 | 1 |
| Alkermes, Inc. | $19.61 | 1 |
| Neurocrine BioSciences, Inc. | $17.31 | 1 |
| Otsuka America Pharmaceutical, Inc. | $13.32 | 1 |
By program year
Records — PY2024 (8)
| Record ID | Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Source |
|---|---|---|---|---|---|---|---|
| 1078183523 | Janssen Pharmaceuticals, Inc | $23.70 | 12/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1118895428 | Otsuka America Pharmaceutical, Inc. | $13.32 | 06/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1120502344 | Alkermes, Inc. | $19.61 | 11/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1147879495 | Supernus Pharmaceuticals, Inc. | $17.00 | 10/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1147902220 | Supernus Pharmaceuticals, Inc. | $66.65 | 11/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1148329245 | Axsome Therapeutics, Inc. | $21.61 | 01/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1148329247 | Axsome Therapeutics, Inc. | $19.04 | 03/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1150867876 | Neurocrine Biosciences, Inc. | $17.31 | 11/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.